Ricevi le ultime notizie sulle azioni Standard BioTools con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di LAB

Ultime notizie per

Standard BioTools

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

CYAN

Scopri le 3 penny stock sotto $5 che stanno attirando l&#39;interesse degli insider per investimenti significativi.

Gli insider puntano su queste 3 penny stock sotto $5

Standard BioTools Inc

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Tradr 2X Long ALAB Daily ETF

LABORATORIOS FARMACEUTICO by LABORATORIOS FARMACEUTICOS ROVI SA

Laboratorios Farmaceuticos Rovi SA

Landos Biopharma Inc COM NEW

LABS Group

Metasphere Labs Inc

METASPHERE LABS INC by METASPHERE LABS INC.

Earnings

Press Releases

Standard BioTools Reports First Quarter 2025 Financial Results

Health Care

General

Standard BioTools to Host Inaugural "Proteomics Roundtable" Webcast Series

Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

"Mag 7 Undercard Movers: IBO, SNYR, CTOR, PNPN.V, LAB – Breakthroughs in Military Defense, Tech, Medical & Healthcare Fuel Market Buzz"

Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025

Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study

Standard BioTools Reports Second Quarter 2025 Financial Results

Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development

Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025

AIFF

ARAI

CTOR

ILMN

NRXP

PNPNF

PRSO

SNYR

TSXV:PNPN

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A

Bruker

Codexis

Cytek Biosciences

CryoPort

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Comments

Standard BioTools Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO